Athanase Innovation AB (FRA:H6H) EBIT: €18.89 Mil (TTM As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6H Athanase Innovation AB FRA:H6H
26 GF Score
Price €1.77
View Full Analysis

What is Athanase Innovation AB EBIT?

Athanase Innovation AB FRA:H6H -1.12% 26 EBIT is €18.89 Mil as of Dec. 2020. GuruFocus rates FRA:H6H with a GF Score™ of 26/100.

Athanase Innovation AB's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2020 was €17.09 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2020 was €18.89 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Athanase Innovation AB's annualized ROC % for the quarter that ended in Dec. 2020 was -0.70%. Athanase Innovation AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was 109.46%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Athanase Innovation AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was 55.88%.

Athanase Innovation AB  (FRA:H6H) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Athanase Innovation AB's annualized ROC % for the quarter that ended in Dec. 2020 is calculated as:

ROC % (Q: Dec. 2020 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2020 ) + Invested Capital (Q: Dec. 2020 ))/ count )
=-0.224 * ( 1 - 0.16% )/( (63.645 + 0.624)/ 2 )
=-0.2236416/32.1345
=-0.70 %

where

Invested Capital(Q: Jun. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=64.561 - 0.294 - ( 1.422 - max(0, 1.504 - 2.126+1.422))
=63.645

Invested Capital(Q: Dec. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=39.677 - 0.057 - ( 39.672 - max(0, 0.681 - 39.677+39.672))
=0.624

Note: The Operating Income data used here is two times the semi-annual (Dec. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

Athanase Innovation AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2020 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2020  Q: Dec. 2020
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=34.17/( ( (62.435 + max(-0.687, 0)) + (0 + max(-0.682, 0)) )/ 2 )
=34.17/( ( 62.435 + 0 )/ 2 )
=34.17/31.2175
=109.46 %

where Working Capital is:

Working Capital(Q: Jun. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.426 + 0 + 0) - (0.294 + 0 + 0.819)
=-0.687

Working Capital(Q: Dec. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + -0.00099999999999767) - (0.057 + 0 + 0.624)
=-0.682

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2020) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Athanase Innovation AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2020 )
=18.892/33.806
=55.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB EBIT Related Terms

Athanase Innovation AB EBIT Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB EBIT Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
EBIT
0.00 2.03 2.08

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
EBIT Get a 7-Day Free Trial 1.05 1.06 0.29 1.81 17.09

FRA:H6H vs : EBIT Comparison

For the Asset Management subindustry, Athanase Innovation AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Athanase Innovation AB EV-to-EBIT vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's EV-to-EBIT falls into.


FRA:H6H
26GF Score
Athanase Innovation AB FRA:H6H
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €18.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €18.89 Mil mean?
Athanase Innovation AB (FRA:H6H) has a EBIT of €18.89 Mil as of Dec. 2020. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Athanase Innovation AB.
Is Athanase Innovation AB's EBIT too high?
Athanase Innovation AB's current EBIT is €18.89 Mil. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's EBIT compare to ?
Athanase Innovation AB's EBIT of €18.89 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Asset Management company?
A good EBIT depends on the Asset Management industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Athanase Innovation AB. Athanase Innovation AB's current EBIT is €18.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (FRA:H6H) has a current EBIT of €18.89 Mil. The current EBIT is €18.89 Mil. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Athanase Innovation AB (FRA:H6H), the current EBIT is €18.89 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Comparable Companies
Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for FRA:H6H

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.77
Price